286 related articles for article (PubMed ID: 37958873)
1. Involvement of Lipophagy and Chaperone-Mediated Autophagy in the Pathogenesis of Non-Alcoholic Fatty Liver Disease by Regulation of Lipid Droplets.
Mastoridou EM; Goussia AC; Kanavaros P; Charchanti AV
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958873
[TBL] [Abstract][Full Text] [Related]
2. Research Progress on Lipophagy-Mediated Exercise Intervention in Non-Alcoholic Fatty Liver Disease.
Li X; Yang Y; Sun Y; Ding S
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542126
[TBL] [Abstract][Full Text] [Related]
3. Autophagy and Lipid Droplets in the Liver.
Martinez-Lopez N; Singh R
Annu Rev Nutr; 2015; 35():215-37. PubMed ID: 26076903
[TBL] [Abstract][Full Text] [Related]
4. The ménage à trois of autophagy, lipid droplets and liver disease.
Filali-Mouncef Y; Hunter C; Roccio F; Zagkou S; Dupont N; Primard C; Proikas-Cezanne T; Reggiori F
Autophagy; 2022 Jan; 18(1):50-72. PubMed ID: 33794741
[TBL] [Abstract][Full Text] [Related]
5. Lipophagy: A potential therapeutic target for nonalcoholic and alcoholic fatty liver disease.
Han YH; He XM; Jin MH; Sun HN; Kwon T
Biochem Biophys Res Commun; 2023 Sep; 672():36-44. PubMed ID: 37336123
[TBL] [Abstract][Full Text] [Related]
6. PNPLA3 variant M148 causes resistance to starvation-mediated lipid droplet autophagy in human hepatocytes.
Negoita F; Blomdahl J; Wasserstrom S; Winberg ME; Osmark P; Larsson S; Stenkula KG; Ekstedt M; Kechagias S; Holm C; Jones HA
J Cell Biochem; 2019 Jan; 120(1):343-356. PubMed ID: 30171718
[TBL] [Abstract][Full Text] [Related]
7. Naringin Protects against Non-Alcoholic Fatty Liver Disease by Promoting Autophagic Flux and Lipophagy.
Guan L; Guo L; Zhang H; Liu H; Zhou W; Zhai Y; Yan X; Men X; Peng L
Mol Nutr Food Res; 2024 Feb; 68(3):e2200812. PubMed ID: 38054638
[TBL] [Abstract][Full Text] [Related]
8. Emerging role of lipophagy in liver disorders.
Nazeer B; Khawar MB; Khalid MU; Hamid SE; Rafiq M; Abbasi MH; Sheikh N; Ali A; Fatima H; Ahmad S
Mol Cell Biochem; 2024 Jan; 479(1):1-11. PubMed ID: 36943663
[TBL] [Abstract][Full Text] [Related]
9. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
Mashek DG
Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
[TBL] [Abstract][Full Text] [Related]
10. Roles of organelle-specific autophagy in hepatocytes in the development and treatment of non-alcoholic fatty liver disease.
Zhang Y; Chen Y
Chin Med J (Engl); 2022 Jul; 135(14):1673-1681. PubMed ID: 35950774
[TBL] [Abstract][Full Text] [Related]
11. Ajugol enhances TFEB-mediated lysosome biogenesis and lipophagy to alleviate non-alcoholic fatty liver disease.
Zhang H; Lu J; Liu H; Guan L; Xu S; Wang Z; Qiu Y; Liu H; Peng L; Men X
Pharmacol Res; 2021 Dec; 174():105964. PubMed ID: 34732369
[TBL] [Abstract][Full Text] [Related]
12. Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways.
Zhao T; Wu K; Hogstrand C; Xu YH; Chen GH; Wei CC; Luo Z
Cell Mol Life Sci; 2020 May; 77(10):1987-2003. PubMed ID: 31392349
[TBL] [Abstract][Full Text] [Related]
13. Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion.
Minami Y; Hoshino A; Higuchi Y; Hamaguchi M; Kaneko Y; Kirita Y; Taminishi S; Nishiji T; Taruno A; Fukui M; Arany Z; Matoba S
Nat Commun; 2023 Jul; 14(1):4084. PubMed ID: 37443159
[TBL] [Abstract][Full Text] [Related]
14. Liver X Receptor Alpha Activation Inhibits Autophagy and Lipophagy in Hepatocytes by Dysregulating Autophagy-Related 4B Cysteine Peptidase and Rab-8B, Reducing Mitochondrial Fuel Oxidation.
Kim YS; Nam HJ; Han CY; Joo MS; Jang K; Jun DW; Kim SG
Hepatology; 2021 Apr; 73(4):1307-1326. PubMed ID: 32557804
[TBL] [Abstract][Full Text] [Related]
15. Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.
Wang Y; Zhao H; Li X; Wang Q; Yan M; Zhang H; Zhao T; Zhang N; Zhang P; Peng L; Li P
J Nutr Biochem; 2019 Nov; 73():108214. PubMed ID: 31520816
[TBL] [Abstract][Full Text] [Related]
16. The Role of Lipophagy in the Development and Treatment of Non-Alcoholic Fatty Liver Disease.
Grefhorst A; van de Peppel IP; Larsen LE; Jonker JW; Holleboom AG
Front Endocrinol (Lausanne); 2020; 11():601627. PubMed ID: 33597924
[TBL] [Abstract][Full Text] [Related]
17. Phillygenin ameliorates nonalcoholic fatty liver disease via TFEB-mediated lysosome biogenesis and lipophagy.
Zhou W; Yan X; Zhai Y; Liu H; Guan L; Qiao Y; Jiang J; Peng L
Phytomedicine; 2022 Aug; 103():154235. PubMed ID: 35716542
[TBL] [Abstract][Full Text] [Related]
18. SIRT3 promotes lipophagy and chaperon-mediated autophagy to protect hepatocytes against lipotoxicity.
Zhang T; Liu J; Shen S; Tong Q; Ma X; Lin L
Cell Death Differ; 2020 Jan; 27(1):329-344. PubMed ID: 31160717
[TBL] [Abstract][Full Text] [Related]
19. Lipophagy and liver disease: New perspectives to better understanding and therapy.
Zhang Z; Yao Z; Chen Y; Qian L; Jiang S; Zhou J; Shao J; Chen A; Zhang F; Zheng S
Biomed Pharmacother; 2018 Jan; 97():339-348. PubMed ID: 29091883
[TBL] [Abstract][Full Text] [Related]
20. The hepatitis B virus promotes the progression of non-alcoholic fatty liver disease through incomplete autophagy.
Wang Y; Li J; Wang S; Pang Y; Liu P; Xie B; Dou S; Yang T; Liu X; Shi Y; Chen D
Free Radic Biol Med; 2023 Aug; 204():326-336. PubMed ID: 37244371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
